The role and clinical significance of tumor-associated macrophages in the epithelial–mesenchymal transition of lung cancer
Liao Lei,
No information about this author
Yingxia Wang,
No information about this author
Susu Fan
No information about this author
et al.
Frontiers in Oncology,
Journal Year:
2025,
Volume and Issue:
15
Published: April 15, 2025
Lung
cancer
remains
the
leading
cause
of
cancer-related
mortality
worldwide.
Tumor-associated
macrophages
(TAMs)
and
epithelial-mesenchymal
transition
(EMT)
are
key
drivers
lung
metastasis
drug
resistance.
M2-polarized
TAMs
dominate
immunosuppressive
tumor
microenvironment
(TME)
promote
EMT
through
cytokines
such
as
TGF-β,
IL-6,
CCL2.
Conversely,
EMT-transformed
cells
reinforce
TAM
recruitment
M2
polarization
immunomodulatory
factors
CCL2
ZEB1,
thereby
establishing
a
bidirectional
interplay
that
fuels
progression.
Current
evidence
on
this
interaction
fragmented,
comprehensive
review
TAM-EMT
regulatory
network
its
therapeutic
implications
is
lacking.
This
systematically
integrates
mechanisms
between
EMT,
highlighting
their
roles
in
It
also
summarizes
emerging
strategies
targeting
process,
emphasizing
potential
for
clinical
translation.
study
fills
gap
systematic
reviews
providing
theoretical
foundation
future
research
development
novel
therapies.
Language: Английский
Targeting oxygenases could be a viable anti-metastatic approach in cancer therapy
Pengfei Shi,
No information about this author
Jie Xu,
No information about this author
Hongjuan Cui
No information about this author
et al.
International Journal of Biological Macromolecules,
Journal Year:
2025,
Volume and Issue:
unknown, P. 143375 - 143375
Published: April 1, 2025
Language: Английский
Macranthoidin B restrains the epithelial-mesenchymal transition through COX-2/PGE2 pathway in endometriosis
Yi Ding,
No information about this author
Xiaoqian Yang,
No information about this author
Qinghua Wei
No information about this author
et al.
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: Dec. 12, 2024
Introduction
Macranthoidin
B
is
one
of
the
primary
and
unique
triterpenoid
saponin
metabolites
from
Lonicera
macranthoides
Hand.
–Mazz,
which
used
to
treat
endometriosis
(EMS)
in
traditional
Chinese
medicine.
However,
effect
macranthoidin
remains
unknown
EMS.
This
study
aimed
elucidate
mechanism
Methods
Using
rat
autograft
EMS
model,
volume
ectopic
endothelium,
histopathology,
serum
E
2
PROG
were
evaluated
after
B’s
treatment.
In
endometriotic
stromal
HEC1-B
cells,
invasion
metastasis
assessed
by
scratch
wound
Transwell
tests.
The
epithelial-mesenchymal
transition
COX-2/PGE
pathway
examined
vivo
vitro
.
combined
with
LPS
or
celecoxib.
Results
a
suppressed
lesion
volume,
improved
histopathological
morphology,
regulated
estradiol
(E2)
progesterone
(PROG)
levels.
Additionally,
inhibited
cells
cells.
Mechanistically,
both
LPS,
COX-2/PGE2
activator,
showed
promotion
transition,
metastasis.
exhibited
antagonistic
effects
against
LPS.
Celecoxib,
inhibitor,
restrained
celecoxib
was
enhanced
B.
Discussion
prevents
through
It
will
facilitate
development
broaden
its
potential
application.
Language: Английский